ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s stock price shot up 4% during mid-day trading on Tuesday . The company traded as high as $1.30 and last traded at $1.29. 33,981 shares changed hands during trading, an increase of 67% from the average session volume of 20,327 shares. The stock had previously closed at $1.24.
ImmunoPrecise Antibodies Stock Performance
The stock has a 50 day simple moving average of $1.66 and a 200-day simple moving average of $1.58.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- What Are Dividend Challengers?
- Comprehensive PepsiCo Stock Analysis
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What Are Growth Stocks and Investing in Them
- Bear Market Funds to Watch This Year
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.